These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 11397398

  • 1. Development of a preliminary physiologically based toxicokinetic (PBTK) model for 1,3-butadiene risk assessment.
    Sweeney LM, Himmelstein MW, Gargas ML.
    Chem Biol Interact; 2001 Jun 01; 135-136():303-22. PubMed ID: 11397398
    [Abstract] [Full Text] [Related]

  • 2. Insights into the toxicokinetics and toxicodynamics of 1,3-butadiene.
    Bond JA, Medinsky MA.
    Chem Biol Interact; 2001 Jun 01; 135-136():599-614. PubMed ID: 11397415
    [Abstract] [Full Text] [Related]

  • 3. Development of a physiologically based toxicokinetic model for butadiene and four major metabolites in humans: global sensitivity analysis for experimental design issues.
    Brochot C, Smith TJ, Bois FY.
    Chem Biol Interact; 2007 May 01; 167(3):168-83. PubMed ID: 17397815
    [Abstract] [Full Text] [Related]

  • 4. Mutational spectrum of 1,3-butadiene and metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane to assess mutagenic mechanisms.
    Recio L, Steen AM, Pluta LJ, Meyer KG, Saranko CJ.
    Chem Biol Interact; 2001 Jun 01; 135-136():325-41. PubMed ID: 11397399
    [Abstract] [Full Text] [Related]

  • 5. Genotoxicity of 1,3-butadiene and its epoxy intermediates.
    Walker VE, Walker DM, Meng Q, McDonald JD, Scott BR, Seilkop SK, Claffey DJ, Upton PB, Powley MW, Swenberg JA, Henderson RF, Health Review Committee.
    Res Rep Health Eff Inst; 2009 Aug 01; (144):3-79. PubMed ID: 20017413
    [Abstract] [Full Text] [Related]

  • 6. Metabolism of 1,3-butadiene to toxicologically relevant metabolites in single-exposed mice and rats.
    Filser JG, Hutzler C, Meischner V, Veereshwarayya V, Csanády GA.
    Chem Biol Interact; 2007 Mar 20; 166(1-3):93-103. PubMed ID: 16616907
    [Abstract] [Full Text] [Related]

  • 7. In vivo doses of butadiene epoxides as estimated from in vitro enzyme kinetics by using cob(I)alamin and measured hemoglobin adducts: an inter-species extrapolation approach.
    Motwani HV, Törnqvist M.
    Toxicol Appl Pharmacol; 2014 Dec 15; 281(3):276-84. PubMed ID: 25448046
    [Abstract] [Full Text] [Related]

  • 8. Physiologically based pharmacokinetic modeling of 1,3-butadiene, 1,2-epoxy-3-butene, and 1,2:3,4-diepoxybutane toxicokinetics in mice and rats.
    Sweeney LM, Schlosser PM, Medinsky MA, Bond JA.
    Carcinogenesis; 1997 Apr 15; 18(4):611-25. PubMed ID: 9111190
    [Abstract] [Full Text] [Related]

  • 9. Genetic effects of 1,3-butadiene and associated risk for heritable damage.
    Pacchierotti F, Adler ID, Anderson D, Brinkworth M, Demopoulos NA, Lähdetie J, Osterman-Golkar S, Peltonen K, Russo A, Tates A, Waters R.
    Mutat Res; 1998 Jan 16; 397(1):93-115. PubMed ID: 9463556
    [Abstract] [Full Text] [Related]

  • 10. Cellular and molecular basis for species, sex and tissue differences in 1,3-butadiene metabolism.
    Elfarra AA, Krause RJ, Kemper RA.
    Chem Biol Interact; 2001 Jun 01; 135-136():239-48. PubMed ID: 11397394
    [Abstract] [Full Text] [Related]

  • 11. 1,3-Butadiene: I. Review of metabolism and the implications to human health risk assessment.
    Kirman CR, Albertini RJ, Sweeney LM, Gargas ML.
    Crit Rev Toxicol; 2010 Oct 01; 40 Suppl 1():1-11. PubMed ID: 20868266
    [Abstract] [Full Text] [Related]

  • 12. Butadiene diolepoxide- and diepoxybutane-derived DNA adducts at N7-guanine: a high occurrence of diolepoxide-derived adducts in mouse lung after 1,3-butadiene exposure.
    Koivisto P, Kilpeläinen I, Rasanen I, Adler ID, Pacchierotti F, Peltonen K.
    Carcinogenesis; 1999 Jul 01; 20(7):1253-9. PubMed ID: 10383898
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the biotransformation of 1,3-butadiene and its metabolite, butadiene monoepoxide, by hepatic and pulmonary tissues from humans, rats and mice.
    Csanády GA, Guengerich FP, Bond JA.
    Carcinogenesis; 1992 Jul 01; 13(7):1143-53. PubMed ID: 1638680
    [Abstract] [Full Text] [Related]

  • 14. Macromolecular adducts of butadiene.
    Tretyakova NYu, Lin YP, Upton PB, Sangaiah R, Swenberg JA.
    Toxicology; 1996 Oct 28; 113(1-3):70-6. PubMed ID: 8901884
    [Abstract] [Full Text] [Related]

  • 15. 1,3-Butadiene working group report.
    Adler ID, Cochrane J, Osterman-Golkar S, Skopek TR, Sorsa M, Vogel E.
    Mutat Res; 1995 Aug 28; 330(1-2):101-14. PubMed ID: 7623862
    [Abstract] [Full Text] [Related]

  • 16. Metabolism of 1,3-butadiene: inhalation pharmacokinetics and tissue dosimetry of butadiene epoxides in rats and mice.
    Himmelstein MW, Turner MJ, Asgharian B, Bond JA.
    Toxicology; 1996 Oct 28; 113(1-3):306-9. PubMed ID: 8901914
    [Abstract] [Full Text] [Related]

  • 17. Clastogenic effects of 1,3-butadiene and its metabolites 1,2-epoxybutene and 1,2,3,4-diepoxybutane in splenocytes and germ cells of rats and mice in vivo.
    Xiao Y, Tates AD.
    Environ Mol Mutagen; 1995 Oct 28; 26(2):97-108. PubMed ID: 7556116
    [Abstract] [Full Text] [Related]

  • 18. Exposure-response of 1,2:3,4-diepoxybutane-specific N-terminal valine adducts in mice and rats after inhalation exposure to 1,3-butadiene.
    Georgieva NI, Boysen G, Bordeerat N, Walker VE, Swenberg JA.
    Toxicol Sci; 2010 Jun 28; 115(2):322-9. PubMed ID: 20176624
    [Abstract] [Full Text] [Related]

  • 19. 1,2:3,4-Diepoxybutane in blood of male B6C3F1 mice and male Sprague-Dawley rats exposed to 1,3-butadiene.
    Csanády GA, Steinhoff R, Riester MB, Semder B, Pütz C, Li Q, Richter N, Kessler W, Klein D, Filser JG.
    Toxicol Lett; 2011 Dec 15; 207(3):286-90. PubMed ID: 21983653
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.